Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 43,411,663
- Total 13F shares
- 16,892,813
- Share change
- -1,693,988
- Total reported value
- $245,597,815
- Put/Call ratio
- 43%
- Price per share
- $14.57
- Number of holders
- 87
- Value change
- -$23,967,610
- Number of buys
- 33
- Number of sells
- 36
Quarterly Holders Quick Answers
What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 22978P106:
Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13F
|
Company |
6.2%
|
2,677,666
|
$31,195,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.9%
|
2,148,798
|
$25,034,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
1,557,718
|
$18,147,000 | — | 30 Jun 2021 | |
| Corriente Advisors, LLC |
13F
|
Company |
3.4%
|
1,486,986
|
$17,323,000 | — | 30 Jun 2021 | |
| Slate Path Capital LP |
13F
|
Company |
3.4%
|
1,483,619
|
$17,284,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
1,470,075
|
$17,126,000 | — | 30 Jun 2021 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.6%
|
704,220
|
$8,204,000 | — | 30 Jun 2021 | |
| Woodline Partners LP |
13F
|
Company |
1.5%
|
667,224
|
$7,773,000 | — | 30 Jun 2021 | |
| Prosight Management, LP |
13F
|
Company |
1.5%
|
630,364
|
$7,344,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
516,319
|
$6,015,000 | — | 30 Jun 2021 | |
| Robertson Stephens Wealth Management, LLC |
13F
|
Company |
1.1%
|
478,500
|
$5,574,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.98%
|
427,348
|
$4,978,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.91%
|
394,650
|
$4,598,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.74%
|
319,315
|
$3,721,000 | — | 30 Jun 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.69%
|
298,000
|
$3,472,000 | — | 30 Jun 2021 | |
| ADVISORY RESEARCH INC |
13F
|
Company |
0.59%
|
256,000
|
$2,982,000 | — | 30 Jun 2021 | |
| SANDERS MORRIS HARRIS LLC |
13F
|
Company |
0.57%
|
247,924
|
$2,772,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.53%
|
229,333
|
$2,672,000 | — | 30 Jun 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.46%
|
200,868
|
$2,340,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.46%
|
199,560
|
$2,325,000 | — | 30 Jun 2021 | |
| Bleichroeder LP |
13F
|
Company |
0.4%
|
175,000
|
$2,039,000 | — | 30 Jun 2021 | |
| Carlson Capital, L.P. |
13F
|
Company |
0.35%
|
150,700
|
$1,756,000 | — | 30 Jun 2021 | |
| P.A.W. CAPITAL CORP |
13F
|
Company |
0.29%
|
125,000
|
$1,456,000 | — | 30 Jun 2021 | |
| Voss Capital, LP |
13F
|
Company |
0.29%
|
125,000
|
$1,456,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
100,538
|
$1,171,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.22%
|
96,245
|
$1,121,000 | — | 30 Jun 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.19%
|
83,125
|
$968,000 | — | 30 Jun 2021 | |
| Sigma Planning Corp |
13F
|
Company |
0.19%
|
81,701
|
$952,000 | — | 30 Jun 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.19%
|
80,721
|
$940,000 | — | 30 Jun 2021 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.15%
|
65,886
|
$768,000 | — | 30 Jun 2021 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.14%
|
62,563
|
$728,000 | — | 30 Jun 2021 | |
| Swiss National Bank |
13F
|
Company |
0.14%
|
60,400
|
$704,000 | — | 30 Jun 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.12%
|
52,552
|
$612,000 | — | 30 Jun 2021 | |
| APOGEM CAPITAL LLC |
13F
|
Company |
0.11%
|
47,953
|
$559,000 | — | 30 Jun 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.1%
|
45,114
|
$526,000 | — | 30 Jun 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.09%
|
41,060
|
$478,000 | — | 30 Jun 2021 | |
| Rock Creek Group, LP |
13F
|
Company |
0.08%
|
35,714
|
$416,000 | — | 30 Jun 2021 | |
| PRECEPT MANAGEMENT LLC |
13F
|
Company |
0.08%
|
35,000
|
$408,000 | — | 30 Jun 2021 | |
| Trexquant Investment LP |
13F
|
Company |
0.08%
|
34,935
|
$407,000 | — | 30 Jun 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.08%
|
33,400
|
$389,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.07%
|
31,725
|
$370,000 | — | 30 Jun 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.07%
|
31,656
|
$369,000 | — | 30 Jun 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
31,014
|
$361,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
30,041
|
$350,000 | — | 30 Jun 2021 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.07%
|
28,396
|
$331,000 | — | 30 Jun 2021 | |
| Caption Management, LLC |
13F
|
Company |
0.06%
|
27,200
|
$316,000 | — | 30 Jun 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.06%
|
27,136
|
$316,000 | — | 30 Jun 2021 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
27,017
|
$315,000 | — | 30 Jun 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.06%
|
26,134
|
$304,000 | — | 30 Jun 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.06%
|
25,642
|
$299,000 | — | 30 Jun 2021 |
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q3 2021
As of 30 Sep 2021,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,892,813 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, Slate Path Capital LP, STATE STREET CORP, Corriente Advisors, LLC, 683 Capital Management, LLC, Prosight Management, LP, GEODE CAPITAL MANAGEMENT, LLC, and Robertson Stephens Wealth Management, LLC.
This page lists
87
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
89
Q3 2021 holders
87
Holder diff
-2
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.